ArticleJournal of cancer research and clinical oncology2024

Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression.

Ziwei Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.